•
Jun 30, 2023

Viridian Therapeutics Q2 2023 Earnings Report

Total Revenue
$72K
Previous year: $256K
-71.9%
EPS
-$1.27
Previous year: -$1.06
+19.8%
Gross Profit
-$360K
Previous year: -$21.5M
-98.3%
Cash and Equivalents
$87.1M
Previous year: $161M
-46.0%
Free Cash Flow
-$45.5M
Previous year: -$18.4M
+147.8%
Total Assets
$351M
Previous year: $170M
+107.0%

Viridian Therapeutics

Viridian Therapeutics